• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pacira BioSciences, Inc. - Common Stock (NQ:PCRX)

25.31 +0.21 (+0.84%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 534,727
Open 25.10
Bid (Size) 10.10 (200)
Ask (Size) 26.80 (5,700)
Prev. Close 25.10
Today's Range 24.85 - 25.66
52wk Range 18.17 - 27.98
Shares Outstanding 44,454,792
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bridge City Capital Loads Up Onto Innovation Stock With Over 31,000 Shares ↗
December 22, 2025
Post-trade holding: 47,342 shares valued at approximately $6.12 million. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
December 18, 2025
From Pacira BioSciences
Via GlobeNewswire

Performance

YTD
+3.5%
+3.5%
1 Month
+3.6%
+3.6%
3 Month
+7.2%
+7.2%
6 Month
+9.2%
+9.2%
1 Year
+35.9%
+35.9%

More News

Read More
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
August 05, 2025
Via Benzinga
News headline image
Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
December 02, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
November 26, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
November 11, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
November 06, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Concludes Patient Enrollment in Part A of Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
November 05, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Enters Exclusive License Agreement with AmacaThera for its Novel Long-acting Analgesic for Postsurgical Pain Control
November 04, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
October 30, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee
October 28, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
October 27, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences to Present New Data from Three Real-World Studies with EXPAREL®
October 23, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®
October 21, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
October 21, 2025
Via Benzinga
News headline image
Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene Therapy
October 20, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
PACIRA BIOSCIENCES INC (NASDAQ:PCRX) Emerges as a Strong Value Investing Opportunity ↗
August 13, 2025
Via Chartmill
News headline image
Pacira (PCRX) Q2 Revenue Rises 1.7% ↗
August 06, 2025
Via The Motley Fool
News headline image
Pacira BioSciences Inc (NASDAQ:PCRX) Reports Mixed Q2 2025 Earnings with EPS Beat but Revenue Miss ↗
August 05, 2025
Via Chartmill
News headline image
Pacira BioSciences Reports Second Quarter 2025 Financial Results
August 05, 2025
From Pacira BioSciences
Via GlobeNewswire
News headline image
Insights Ahead: Pacira BioSciences's Quarterly Earnings ↗
August 04, 2025
Via Benzinga

Frequently Asked Questions

Is Pacira BioSciences, Inc. - Common Stock publicly traded?
Yes, Pacira BioSciences, Inc. - Common Stock is publicly traded.
What exchange does Pacira BioSciences, Inc. - Common Stock trade on?
Pacira BioSciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pacira BioSciences, Inc. - Common Stock?
The ticker symbol for Pacira BioSciences, Inc. - Common Stock is PCRX on the Nasdaq Stock Market
What is the current price of Pacira BioSciences, Inc. - Common Stock?
The current price of Pacira BioSciences, Inc. - Common Stock is 25.31
When was Pacira BioSciences, Inc. - Common Stock last traded?
The last trade of Pacira BioSciences, Inc. - Common Stock was at 01/06/26 04:00 PM ET
What is the market capitalization of Pacira BioSciences, Inc. - Common Stock?
The market capitalization of Pacira BioSciences, Inc. - Common Stock is 1.13B
How many shares of Pacira BioSciences, Inc. - Common Stock are outstanding?
Pacira BioSciences, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap